Product Description
Since last many yearsSaintroy Lifescience is leading manufacture, export and supplierofTenecteplase Injection from Surat, Gujarat, India. Tenecteplase Injection used as a thrombolytic drug.Tenecteplase Is a tissue plasminogen activator (tPA) produced by recombinant DNA technology using an established mammalian cell line (Chinese hamster ovary cells).
Tags: Tenecteplase Injection manufacturer, Tenecteplase Injection exporter,Tenecteplase Injection supplier, and Tenecteplase Injection, whogmp approved Tenecteplase Injectionmanufacturer and supplier, Tenecteplase Injection distributor, Tenecteplase Injectionshipper, Tenecteplase Injection 30 mg Tenecteplase Injection30 mg supplier,Tenecteplase Injection30 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approvedmanufacturing facility in Gujarat, India.
Registration: Saintroy Lifescience is interested in registrationof own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTorCTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy LifescienceTenecteplase Injectionexport to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Reliable Clot DissolutionTenecteplase Injection acts rapidly to dissolve blood clots in stroke and heart attack patients, thereby restoring blood flow and minimizing potential complications. It is engineered to deliver prompt therapeutic action, benefiting patients during critical medical emergencies. Its effectiveness is backed by extensive clinical use and stringent manufacturing standards in India.
Innovative Manufacturing and DistributionProduced by leading Indian pharmaceutical manufacturers, Tenecteplase Injection is supplied worldwide through a robust network of dealers, distributors, and wholesalers. Its precise molecular structure ensures high potency, while compliance with global quality norms guarantees safe distribution to healthcare providers.
FAQ's of Tenecteplase Injection:
Q: How should Tenecteplase Injection be stored to maintain its effectiveness?
A: Tenecteplase Injection should be stored according to special instructions specified by the manufacturer, as it falls under the 'Other' storage category. Always refer to the packaging or consult your supplier for detailed storage guidelines to ensure product stability.
Q: What is the intended medical use of Tenecteplase Injection?
A: Tenecteplase Injection is primarily used for the rapid dissolution of blood clots, especially in acute myocardial infarction (heart attack) cases. Its targeted action supports faster patient recovery and reduces damage to the heart.
Q: When is Tenecteplase Injection administered during medical treatment?
A: This injection is administered as soon as possible during or after the onset of heart attack symptoms, under the supervision of healthcare professionals experienced in clot-dissolving therapies.
Q: Where can I source Tenecteplase Injection in India?
A: The product is widely available from certified dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers throughout India. It is important to purchase from authorized entities to ensure product authenticity.
Q: What is the process for ordering Tenecteplase Injection from a wholesaler?
A: To order, contact a licensed wholesaler or distributor who can verify stock availability and assist with regulatory documentation. Ensure the supplier adheres to all safety and storage protocols during shipment.
Q: How does using Tenecteplase Injection benefit healthcare outcomes?
A: By rapidly breaking down clots, Tenecteplase Injection can significantly decrease the risk of mortality or severe complications in patients experiencing acute heart attacks, thus improving overall survival rates.